X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
53
PharmaCompass offers a list of Velpatasvir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Velpatasvir manufacturer or Velpatasvir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Velpatasvir manufacturer or Velpatasvir supplier.
PharmaCompass also assists you with knowing the Velpatasvir API Price utilized in the formulation of products. Velpatasvir API Price is not always fixed or binding as the Velpatasvir Price is obtained through a variety of data sources. The Velpatasvir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Velpatasvir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Velpatasvir, including repackagers and relabelers. The FDA regulates Velpatasvir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Velpatasvir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Velpatasvir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Velpatasvir supplier is an individual or a company that provides Velpatasvir active pharmaceutical ingredient (API) or Velpatasvir finished formulations upon request. The Velpatasvir suppliers may include Velpatasvir API manufacturers, exporters, distributors and traders.
click here to find a list of Velpatasvir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Velpatasvir Drug Master File in Korea (Velpatasvir KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Velpatasvir. The MFDS reviews the Velpatasvir KDMF as part of the drug registration process and uses the information provided in the Velpatasvir KDMF to evaluate the safety and efficacy of the drug.
After submitting a Velpatasvir KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Velpatasvir API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Velpatasvir suppliers with KDMF on PharmaCompass.
A Velpatasvir written confirmation (Velpatasvir WC) is an official document issued by a regulatory agency to a Velpatasvir manufacturer, verifying that the manufacturing facility of a Velpatasvir active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Velpatasvir APIs or Velpatasvir finished pharmaceutical products to another nation, regulatory agencies frequently require a Velpatasvir WC (written confirmation) as part of the regulatory process.
click here to find a list of Velpatasvir suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Velpatasvir as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Velpatasvir API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Velpatasvir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Velpatasvir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Velpatasvir NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Velpatasvir suppliers with NDC on PharmaCompass.
Velpatasvir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Velpatasvir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Velpatasvir GMP manufacturer or Velpatasvir GMP API supplier for your needs.
A Velpatasvir CoA (Certificate of Analysis) is a formal document that attests to Velpatasvir's compliance with Velpatasvir specifications and serves as a tool for batch-level quality control.
Velpatasvir CoA mostly includes findings from lab analyses of a specific batch. For each Velpatasvir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Velpatasvir may be tested according to a variety of international standards, such as European Pharmacopoeia (Velpatasvir EP), Velpatasvir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Velpatasvir USP).
Market Place
